Printer Friendly

Anavex Life Sciences Corp elects John Harrison to Scientific Advisory Board.

M2 EQUITYBITES-December 11, 2013-Anavex Life Sciences Corp elects John Harrison to Scientific Advisory Board


Biopharmaceutical company Anavex Life Sciences Corp (OTC Markets:AVXL) revealed on Tuesday the election of John Harrison, PhD, to its Scientific Advisory Board.

The company added that Dr Harrison is an internationally acknowledged specialist for design of human clinical outcome measurement in Alzheimer's disease and other cognitive impairments. He has successfully integrated cognitive testing into drug development programmes for many pharmaceutical and biotechnology companies.

Currently, Dr Harrison is a honorary senior lecturer in the Department of Medicine at Imperial College in London, a member of the American Psychological Association, a principal consultant at Metis Cognition Ltd as well as holding chartered psychologist status with the British Psychological Society and chartered scientist status with the UK Science Council.

Previously, Dr Harrison was employed as head of Neuropsychology at CeNeS Pharmaceuticals, principal consultant at CPC Pharma Services and principal scientist at CogState Ltd.

((Comments on this story may be sent to

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Dec 11, 2013
Previous Article:Santander to purchase 8% stake in Bank of Shanghai.
Next Article:Draft tax legislation published by UK government.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters